GN Store Nord Pre-Tax Profit Margin 2016-2024 | GNNDY
GN Store Nord pre-tax profit margin from 2016 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| GN Store Nord Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $2.62B | $0.13B | 5.07% |
| 2024-06-30 | $2.66B | $0.12B | 4.55% |
| 2024-03-31 | $2.65B | $0.11B | 4.07% |
| 2023-12-31 | $2.63B | $0.05B | 1.90% |
| 2023-09-30 | $2.63B | $0.10B | 3.65% |
| 2023-06-30 | $2.62B | $0.09B | 3.44% |
| 2023-03-31 | $2.67B | $0.13B | 4.79% |
| 2022-12-31 | $2.65B | $0.10B | 3.85% |
| 2022-09-30 | $2.54B | $0.13B | 5.19% |
| 2022-06-30 | $2.51B | $0.19B | 7.37% |
| 2022-03-31 | $2.43B | $0.23B | 9.40% |
| 2021-12-31 | $2.51B | $0.36B | 14.38% |
| 2021-09-30 | $2.52B | $0.38B | 14.91% |
| 2021-06-30 | $2.51B | $0.41B | 16.43% |
| 2021-03-31 | $2.29B | $0.33B | 14.20% |
| 2020-12-31 | $2.06B | $0.25B | 11.99% |
| 2020-09-30 | $1.96B | $0.26B | 13.09% |
| 2020-06-30 | $1.82B | $0.20B | 10.86% |
| 2020-03-31 | $1.89B | $0.26B | 13.54% |
| 2019-12-31 | $1.88B | $0.29B | 15.23% |
| 2019-09-30 | $1.85B | $0.27B | 14.71% |
| 2019-06-30 | $1.80B | $0.27B | 14.71% |
| 2019-03-31 | $1.75B | $0.26B | 15.07% |
| 2018-12-31 | $1.68B | $0.26B | 15.19% |
| 2018-09-30 | $1.59B | $0.25B | 15.42% |
| 2018-06-30 | $1.55B | $0.24B | 15.67% |
| 2018-03-31 | $1.50B | $0.24B | 15.72% |
| 2017-12-31 | $1.46B | $0.23B | 15.73% |
| 2017-09-30 | $1.35B | $0.22B | 16.58% |
| 2017-06-30 | $1.31B | $0.21B | 15.90% |
| 2017-03-31 | $1.30B | $0.20B | 15.74% |
| 2016-12-31 | $1.29B | $0.21B | 16.17% |
| 2016-09-30 | $1.30B | $0.46B | 35.53% |
| 2016-06-30 | $1.29B | $0.72B | 56.18% |
| 2016-03-31 | $1.25B | $0.98B | 78.41% |
| 2015-12-31 | $1.22B | $1.22B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.864B | $2.630B |
| GN Store Nord A/S offers medical hearing instruments, professional and consumer headsets. The Company's operating segments include GN Netcom, GN ReSound and Others. GN Netcom segment sells hands-free communications solutions in the form of headsets for mobile phones and traditional phones. GN ReSound segment operates within the hearing instrument industry, and produces and sells hearing healthcare instruments and related products. It offers hearing aids and accessories under the ReSound, Beltone and Interton brand names. GN Store Nord A/S is based in Ballerup, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.127B | 25.27 |
| Stryker (SYK) | United States | $138.991B | 31.32 |
| Boston Scientific (BSX) | United States | $131.097B | 37.69 |
| EssilorLuxottica (ESLOY) | France | $109.895B | 0.00 |
| Medtronic (MDT) | Ireland | $103.904B | 15.43 |
| Haleon (HLN) | United Kingdom | $43.864B | 28.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.859B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.052B | 18.70 |
| ResMed (RMD) | United States | $34.830B | 28.62 |
| Terumo (TRUMY) | Japan | $28.875B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.602B | 18.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.325B | 13.58 |
| Insulet (PODD) | United States | $18.698B | 74.46 |
| Baxter (BAX) | United States | $15.062B | 9.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.781B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.800B | 39.43 |
| Bio-Rad Laboratories (BIO) | United States | $9.168B | 31.16 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.208B | 14.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.889B | 19.34 |
| ICU Medical (ICUI) | United States | $3.840B | 36.56 |
| Haemonetics (HAE) | United States | $3.789B | 18.49 |
| Perrigo (PRGO) | Ireland | $3.513B | 10.34 |
| Envista Holdings (NVST) | United States | $3.218B | 23.97 |
| QuidelOrtho (QDEL) | United States | $3.016B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| Neogen (NEOG) | United States | $2.609B | 30.10 |
| LeMaitre Vascular (LMAT) | United States | $2.071B | 50.34 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 29.37 |
| AtriCure (ATRC) | United States | $1.498B | 0.00 |
| InMode (INMD) | Israel | $1.434B | 8.63 |
| AdaptHealth (AHCO) | United States | $1.383B | 9.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.271B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.968B | 0.00 |
| Owens & Minor (OMI) | United States | $0.965B | 7.54 |
| CeriBell (CBLL) | United States | $0.964B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.879B | 15.49 |
| Evolus (EOLS) | United States | $0.690B | 0.00 |
| Omeros (OMER) | United States | $0.597B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.594B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.584B | 25.75 |
| Surmodics (SRDX) | United States | $0.568B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.452B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.439B | 0.00 |
| Quanterix (QTRX) | United States | $0.403B | 0.00 |
| ZimVie (ZIMV) | United States | $0.375B | 31.63 |
| Biote (BTMD) | United States | $0.331B | 7.26 |
| Valneva SE (VALN) | France | $0.324B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.311B | 29.56 |
| Canopy Growth (CGC) | Canada | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
| Zynex (ZYXI) | United States | $0.263B | 55.00 |
| High Tide (HITI) | Canada | $0.242B | 100.33 |
| Aurora Cannabis (ACB) | Canada | $0.234B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 14.29 |
| Sanuwave Health (SNWV) | United States | $0.201B | 2.82 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.190B | 0.00 |
| Brainsway (BWAY) | Israel | $0.174B | 92.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.17 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.81 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Exagen (XGN) | United States | $0.091B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.067B | 34.67 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.74 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |